Green Square Capital Advisors LLC Bristol Myers Squibb CO Transaction History

Green Square Capital Advisors LLC

$723 Million
Q4 2024

A detailed history of Green Square Capital Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Green Square Capital Advisors LLC holds 36,310 shares of BMY stock, worth $2.03 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

36,310

Previous 43,493 16.52%

Holding current value

$2.03 Million

Previous $2.25 Million 8.76%

% of portfolio

0.28%

Previous 0.32%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$51.92 - $59.94 $372,941 - $430,549	-7,183 Reduced 16.52%	36,310 $2.05 Million
Q3 2024 Nov 07, 2024	BUY	$39.66 - $51.75 $409,013 - $533,697	10,313 Added 31.08%	43,493 $2.25 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $180,199 - $237,236	-4,477 Reduced 11.89%	33,180 $1.38 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $1.47 Million - $1.67 Million	30,718 Added 442.69%	37,657 $2.04 Million
Q4 2023 Jan 18, 2024	SELL	$48.48 - $57.85 $1.11 Million - $1.32 Million	-22,883 Reduced 76.73%	6,939 $356,000
Q3 2023 Oct 10, 2023	BUY	$57.89 - $64.73 $13,662 - $15,276	236 Added 0.8%	29,822 $1.73 Million
Q2 2023 Jul 13, 2023	BUY	$63.71 - $70.74 $20,004 - $22,212	314 Added 1.07%	29,586 $1.89 Million
Q1 2023 Apr 14, 2023	BUY	$65.71 - $74.53 $71,295 - $80,865	1,085 Added 3.85%	29,272 $2.03 Million
Q4 2022 Feb 15, 2023	BUY	$68.48 - $81.09 $39,581 - $46,870	578 Added 2.09%	28,187 $2.03 Million
Q3 2022 Oct 31, 2022	BUY	$0.13 - $76.84 $9 - $5,609	73 Added 0.27%	27,609 $1.96 Million
Q2 2022 Jul 20, 2022	BUY	$72.62 - $79.98 $653 - $719	9 Added 0.03%	27,536 $2.12 Million
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $1.13 Million - $1.35 Million	18,333 Added 199.4%	27,527 $2.01 Million
Q4 2021 Mar 08, 2022	SELL	$53.63 - $62.52 $866,553 - $1.01 Million	-16,158 Reduced 63.73%	9,194 $573,000
Q3 2021 Oct 19, 2021	BUY	$59.17 - $69.31 $64,376 - $75,409	1,088 Added 4.48%	25,352 $1.5 Million
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $231,233 - $251,813	3,735 Added 18.19%	24,264 $1.62 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $17,327 - $19,488	292 Added 1.44%	20,529 $1.3 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $1.17 Million - $1.32 Million	20,237 New	20,237 $1.26 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $188,511 - $224,776	-4,178 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $14,091 - $18,273	289 Added 7.43%	4,178 $217,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $4,194 - $4,731	76 Added 1.99%	3,889 $241,000
Q2 2018 Aug 20, 2018	SELL	$50.53 - $62.98 $8,337 - $10,391	-165 Reduced 4.15%	3,813 $211,000
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $11,984 - $13,796	200 Added 5.29%	3,978 $252,000
Q4 2017 Feb 22, 2018	SELL	$59.94 - $65.35 $122,877 - $133,967	-2,050 Reduced 35.18%	3,778 $232,000
Q3 2017 Nov 15, 2017	BUY	$55.23 - $63.74 $110,460 - $127,480	2,000 Added 52.25%	5,828 $371,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,828	3,828 $213,000

Others Institutions Holding BMY

# of Institutions

2,751

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Square Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Square Capital Advisors LLC with notifications on news.

Account

Green Square Capital Advisors LLC Bristol Myers Squibb CO Transaction History